A randomized controlled study of integrated traditional Chinese and western medicine prevention and treatment plan for borderline hypertension

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: Experimental group:Ershu Tianma Granules 1 dose,2/d;Control group:Ershu Tianma placebo Granules 1 dose,2/d; CONDITION: Borderline Hypertension PRIMARY OUTCOME: Consulting room blood pressure; SECONDARY OUTCOME: Body mass index;Waist Circumference;Homocysteine;Home Self‐Test Blood Pressure;Uric Acid;Chinese medicine evidence score;Fasting blood sugar;Ambulatory blood pressure mean blood pressure values;Ambulatory blood pressure load values and circadian rhythms;C‐reactive protein;Serum lipid level;Quality of life; INCLUSION CRITERIA: ?No antihypertensive medication in the last 4 weeks and three consecutive upper limb brachial artery sitting blood pressure measurements on non‐same day within 1 week, systolic blood pressure (SBP) 120‐139 mmHg and/or diastolic blood pressure (DBP) 80‐89 mmHg. ?Age 18‐65 years old, gender not limited. ?Meet the diagnostic criteria of phlegm‐dampness internal obstruction evidence. ?Voluntary participation and cooperation with the investigator by signing the written informed consent.
Epistemonikos ID: 5477b5e4112efd53feac89fdd20930b647cab2d6
First added on: Aug 26, 2024